… help in the therapeutic efficacy of doxorubicin-loaded liposome in syngeneic CT26 colorectal
mice … , in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer. Int J …

… Relevant clues that correlated the efficacy of antitumor immune … Vasculature-targeted tumor
necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer…

… Moreover, tumor vasculature targeted NPs have some … fold) as compared with the clinically
used liposomal doxorubicin [63]. … Evaluation of anti-tumor effects of different PTX formulations …

… ’ benefits only some tumors and their efficacy improvement could … Recently, a combination
of radiotherapy, liposomal … solid tumors and showed promising tolerability and anti-tumor …

… delivery and side effects of liposomal drugs. Thus, liposomal doxorubicin accumulates in
tumors to a greater degree than free drugs, albeit therapeutic efficacy is not much improved. (2,3…

… 4d), and the combination of CA4-NPs and MMP9-Dox-NPs exhibited excellent anti-tumor
efficacy in both orthotopic 4 T1 tumor model and subcutaneous C26 tumor model (Fig. 4e, f). …

… However, poor solubility in water, low drug-targeting property and low drug-utilization
efficiency limit the further application of PTL. To further improve the efficacy of cancer treatment, …

… of long-circulating liposomes, for example, doxorubicin (DOX)-… improve their anticancer
efficacy in some tumor models [20]. … promising avenue for targeted anti-tumor therapy. Thus, the …

… ligands increased the cytotoxic efficacy of liposomal doxorubicin in several cancer cell lines.
… Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin. Cancer Res…

… CA4P and Doxorubicin (DOX) and exhibited high inhibitory activities on … To monitor the
efficiency of the treatment, tumor volume and … the mechanism of the anti-tumor response involved. …